New MRI Contrast Agent Can Tell Aggressive Breast Cancer From Other Types
Final thoughts
Zhen-Rong Lu and his team of researchers in Cleveland, Ohio, have created a contrasting agent designed to be used with MRIs to identify breast cancer.
It is safer and more effective than previous contrasting agents and, in fact, can even help the doctor distinguish between types of breast cancer from the beginning of the diagnosis.
This will help healthcare practitioners give patients the treatment they need earlier in the tumor’s development, which is important for catching the cancer before it can cause too much damage to the patient’s system.
References
https://www.sciencedaily.com/releases/2017/09/170925095421.htm
https://www.nature.com/articles/s41467-017-00741-y
https://www.webmd.com/breast-cancer/guide/breast-cancer-types-er-positive-her2-positive
